136 related articles for article (PubMed ID: 7525960)
21. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
[TBL] [Abstract][Full Text] [Related]
22. A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine.
Miyasaka T; Tanaka H; Baba M; Hayakawa H; Walker RT; Balzarini J; De Clercq E
J Med Chem; 1989 Dec; 32(12):2507-9. PubMed ID: 2479745
[No Abstract] [Full Text] [Related]
23. Synthesis and evaluation of the anti-HIV activity of aza and deaza analogues of isoddA and their phosphates as prodrugs.
Franchetti P; Cappellacci L; Grifantini M; Messini L; abu Sheikha G; Loi AG; Tramontano E; de Montis A; Spiga MG; La Colla P
J Med Chem; 1994 Oct; 37(21):3534-41. PubMed ID: 7523675
[TBL] [Abstract][Full Text] [Related]
24. Nonnucleoside HIV-1 reverse transcriptase inhibitors; part 3. Synthesis and antiviral activity of 5-alkyl-2-[(aryl and alkyloxyl-carbonylmethyl)thio]-6-(1-naphthylmethyl) pyrimidin-4(3H)-ones.
He Y; Chen F; Yu X; Wang Y; De Clercq E; Balzarini J; Pannecouque C
Bioorg Chem; 2004 Dec; 32(6):536-48. PubMed ID: 15530994
[TBL] [Abstract][Full Text] [Related]
25. 3'-Spiro nucleosides, a new class of specific human immunodeficiency virus type 1 inhibitors: synthesis and antiviral activity of [2'-5'-bis-O-(tert-butyldimethylsilyl)-beta-D-xylo- and -ribofuranose]-3'-spiro-5"-[4"-amino-1",2"-oxathiole 2",2"-dioxide] (TSAO) pyrimidine nucleosides.
Camarasa MJ; Pérez-Pérez MJ; San-Félix A; Balzarini J; De Clercq E
J Med Chem; 1992 Jul; 35(15):2721-7. PubMed ID: 1495006
[TBL] [Abstract][Full Text] [Related]
26. Imidazo[1,5-b]pyridazine-d4T conjugates: synthesis and anti-human immunodeficiency virus evaluation.
Renoud-Grappin M; Fossey C; Fontaine G; Ladurée D; Aubertin AM; Kirn A
Antivir Chem Chemother; 1998 May; 9(3):205-23. PubMed ID: 9875400
[TBL] [Abstract][Full Text] [Related]
27. Specificity of HIV inhibition by modified antisense oligonucleotides.
Abramova T; Blinov V; Vlassov V; Gorn V; Zarytova V; Ivanova E; Konevets D; Plyasunova O; Pokrovsky A; Sandakhchiev L
Nucleic Acids Symp Ser; 1991; (24):283. PubMed ID: 1841341
[No Abstract] [Full Text] [Related]
28. Selective and synergistic inhibition of human immunodeficiency virus type 1 reverse transcriptase by a non-nucleoside inhibitor, MKC-442.
Yuasa S; Sadakata Y; Takashima H; Sekiya K; Inouye N; Ubasawa M; Baba M
Mol Pharmacol; 1993 Oct; 44(4):895-900. PubMed ID: 7694070
[TBL] [Abstract][Full Text] [Related]
29. Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle.
Witvrouw M; Fikkert V; Pluymers W; Matthews B; Mardel K; Schols D; Raff J; Debyser Z; De Clercq E; Holan G; Pannecouque C
Mol Pharmacol; 2000 Nov; 58(5):1100-8. PubMed ID: 11040059
[TBL] [Abstract][Full Text] [Related]
30. New arylpyrido-diazepine and -thiodiazepine derivatives are potent and highly selective HIV-1 inhibitors targeted at the reverse transcriptase.
Bellarosa D; Antonelli G; Bambacioni F; Giannotti D; Viti G; Nannicini R; Giachetti A; Dianzani F; Witvrouw M; Pauwels R; Desmyter J; De Clercq E
Antiviral Res; 1996 May; 30(2-3):109-24. PubMed ID: 8783803
[TBL] [Abstract][Full Text] [Related]
31. An approach towards the synthesis of potential metal-chelating TSAO-T derivatives as bidentate inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
Chamorro C; Camarasa MJ; Pérez-Pérez MJ; de Clercq E; Balzarini J; San Félix A
Antivir Chem Chemother; 1998 Sep; 9(5):413-22. PubMed ID: 9875394
[TBL] [Abstract][Full Text] [Related]
32. Novel series of TSAO-T derivatives. Synthesis and anti-HIV-1 activity of 4-, 5-, and 6-substituted pyrimidine analogues.
San-Félix A; Velázquez S; Pérez-Pérez MJ; Balzarini J; De Clercq E; Camarasa MJ
J Med Chem; 1994 Feb; 37(4):453-60. PubMed ID: 7509877
[TBL] [Abstract][Full Text] [Related]
33. Membrane-permeable dideoxyuridine 5'-monophosphate analogue inhibits human immunodeficiency virus infection.
Sastry JK; Nehete PN; Khan S; Nowak BJ; Plunkett W; Arlinghaus RB; Farquhar D
Mol Pharmacol; 1992 Mar; 41(3):441-5. PubMed ID: 1372082
[TBL] [Abstract][Full Text] [Related]
34. In vitro assessment of compounds for anti-HIV activity.
Patience C; Moore J; Boyd M
Mol Biotechnol; 1994 Feb; 1(1):49-58. PubMed ID: 7532100
[TBL] [Abstract][Full Text] [Related]
35. Novel naphthalenedisulfonic acid anti-HIV-1 agents. Synthesis and activity against reverse transcriptase, virus replication and syncytia formation.
Mohan P; Singh R; Baba M
Drug Des Discov; 1991 Nov; 8(1):69-82. PubMed ID: 1725723
[TBL] [Abstract][Full Text] [Related]
36. First synthesis and evaluation of the inhibitory effects of aza analogues of TSAO on HIV-1 replication.
Nguyen Van Nhien A; Tomassi C; Len C; Marco-Contelles JL; Balzarini J; Pannecouque C; De Clercq E; Postel D
J Med Chem; 2005 Jun; 48(13):4276-84. PubMed ID: 15974581
[TBL] [Abstract][Full Text] [Related]
37. Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.
Taylor DL; Ahmed PS; Chambers P; Tyms AS; Bedard J; Duchaine J; Falardeau G; Lavallée JF; Brown W; Rando RF; Bowlin T
Antivir Chem Chemother; 1999 Mar; 10(2):79-86. PubMed ID: 10335402
[TBL] [Abstract][Full Text] [Related]
38. Anti-AIDS agents. 15. Synthesis and anti-HIV activity of dihydroseselins and related analogs.
Huang L; Kashiwada Y; Cosentino LM; Fan S; Chen CH; McPhail AT; Fujioka T; Mihashi K; Lee KH
J Med Chem; 1994 Nov; 37(23):3947-55. PubMed ID: 7525962
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and anti-HIV-1 activity of a series of imidazo[1,5-b]pyridazines.
Livermore DG; Bethell RC; Cammack N; Hancock AP; Hann MM; Green DV; Lamont RB; Noble SA; Orr DC; Payne JJ
J Med Chem; 1993 Nov; 36(24):3784-94. PubMed ID: 7504733
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587.
Koup RA; Merluzzi VJ; Hargrave KD; Adams J; Grozinger K; Eckner RJ; Sullivan JL
J Infect Dis; 1991 May; 163(5):966-70. PubMed ID: 1708400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
